| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/22/2011 | US7893065 mitogen activated protein kinase inhibitors; 4-(2-Fluoro-4-(methylthio)phenylamino)-N-(2-hydroxyethoxy)-1-methyl-6-oxo-1,6-dihydropyridazine-3-carboxamide; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals |
| 02/22/2011 | US7893052 CGRP receptor antagonists |
| 02/22/2011 | CA2624558C Cross-linked cyclic amine compounds and agents for pest control |
| 02/22/2011 | CA2553879C Viral polymerase inhibitors |
| 02/22/2011 | CA2485909C Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
| 02/22/2011 | CA2470575C Spiroazacyclic compounds as monoamine receptor modulators |
| 02/22/2011 | CA2398163C Therapeutic morpholino-substituted compounds |
| 02/22/2011 | CA2329181C 12,13-modified epothilone derivatives |
| 02/22/2011 | CA2319198C Substituted oxoazaheterocyclyl factor xa inhibitors |
| 02/22/2011 | CA2263409C High molecular weight polymer-based prodrugs |
| 02/17/2011 | WO2011019842A1 Process for the preparation of cathepsin s inhibitors |
| 02/17/2011 | WO2011019780A1 Azaindazoles as btk kinase modulators and use thereof |
| 02/17/2011 | WO2011019634A2 Aryl substituted sulfonamide compounds and their use as anticancer agents |
| 02/17/2011 | WO2011019060A1 Hedgehog signal inhibitor |
| 02/17/2011 | WO2011018384A1 Bi - or tricyclic sterically hindered alkoxyamines and process for their preparation |
| 02/17/2011 | US20110040094 1,3,4-trisubstituted benzenes |
| 02/17/2011 | US20110040088 Fused heterocyclic compounds |
| 02/17/2011 | US20110040086 Novel Beta-Lactam Antibiotics, Methods for Their Production, and Their Use |
| 02/17/2011 | US20110039884 Imidazopyridinones |
| 02/17/2011 | US20110039880 Aryl substituted sulfonamide compounds and their use as anticancer agents |
| 02/17/2011 | US20110039873 SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS HAVING MULTI-TARGET ACTIVITY |
| 02/17/2011 | US20110039870 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof |
| 02/17/2011 | US20110039867 Pyrimidine derivatives which are antagonist of the vitronectin receptor |
| 02/17/2011 | US20110039857 Piperidine and pyroolidine compounds |
| 02/17/2011 | US20110039843 Harmful arthropod control composition, and fused heterocyclic compound |
| 02/17/2011 | US20110039842 Compounds having antiviral properties |
| 02/17/2011 | US20110039840 Spirocyclic derivatives as histone deacetylase inhibitors |
| 02/17/2011 | US20110039832 Dihydro)pyrrolo[2,1-a]isoquinolines |
| 02/17/2011 | US20110039825 Ligands of alpha-adrenoceptors, dopamine, histamine, imidazoline and serotonin receptors and their use |
| 02/17/2011 | US20110039823 Oxazolidinone antibiotics |
| 02/17/2011 | US20110039822 Heterocyclic janus kinase 3 inhibitors |
| 02/17/2011 | US20110038926 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 02/17/2011 | US20110038925 Intravenous formulations of neurokinin-1 antagonists |
| 02/17/2011 | US20110038835 Anilides and analogs as rho kinase inhibitors |
| 02/17/2011 | US20110037060 Organic light emitting device |
| 02/17/2011 | CA2770904A1 Process for the preparation of cathepsin s inhibitors |
| 02/17/2011 | CA2770403A1 Intravenous formulations of neurokinin-1 antagonists |
| 02/17/2011 | CA2770116A1 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
| 02/17/2011 | CA2769761A1 Bi - or tricyclic sterically hindered alkoxyamines and process for their preparation |
| 02/17/2011 | CA2760516A1 Pyrido[4,3-b]indoles and methods of use |
| 02/16/2011 | EP2284171A1 Amides of diazabicycloalkanes selective for nicotinic acetylcholine receptor sub-types |
| 02/16/2011 | EP2283840A1 The use of mirtazapine for the treatment of sleep disorders. |
| 02/16/2011 | EP2283024A1 4-aryl-2-anilino-pyrimidines as plk kinase inhibitors |
| 02/16/2011 | EP2283014A1 Polymorphs of hydrochloride salt o5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-n-(1-methylpiperidin-4-yl)-9h-pyridoý2,3-b¨indole-7-carboxamideand methods of use therefor |
| 02/16/2011 | EP2283004A1 Amido-thiophene compounds and their use |
| 02/16/2011 | EP2283002A2 Novel inhibitors of hepatitis c virus replication |
| 02/16/2011 | EP1896481B1 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 02/16/2011 | CN101977911A Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/16/2011 | CN101977910A N-azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/16/2011 | CN101977907A Pyrrolidinyl derivatives and uses thereof |
| 02/16/2011 | CN101977655A Indazole derivatives |
| 02/16/2011 | CN101973994A Supercritical extraction method for evodiamine |
| 02/16/2011 | CN101973993A Method for preparing 2-[imidazo[1,2-a]pyridine-3-yl]acetic acid |
| 02/16/2011 | CN101973992A Synthesizing method of moxifloxacin hydrochloride |
| 02/16/2011 | CN101973829A Trifluoromethylation of trifluoromethyl aryl sulfonium salt to heterocyclic compound under metal trigger |
| 02/16/2011 | CN101218241B Pyrrolopyridine derivatives as protein kinase inhibitors |
| 02/15/2011 | USRE42152 FDA Orange book listed patent for plerixafor |
| 02/15/2011 | US7888508 3-(carboxy or carbamoyl)-5-amino-1H-pyrrolo(2,3-b)pyridines; cancer, Alzheimer's disease, viral infections, autoimmune diseases and neurodegenerative disorders; chemical libraries of these compounds |
| 02/15/2011 | US7888507 UV excitable fluorescent energy transfer dyes |
| 02/15/2011 | US7888505 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one carboxylic acids, their esters, and methods of synthesis thereof |
| 02/15/2011 | US7888368 Treatment of drug-resistant tumors |
| 02/15/2011 | US7888359 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives |
| 02/15/2011 | US7888349 Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds |
| 02/15/2011 | US7888344 Fused thiazole derivatives as kinase inhibitors |
| 02/15/2011 | US7888343 Substituted, bicyclic 8-pyrrolidinoxanthines, and methods for their use as inhibitors of dipeptidyl peptidase |
| 02/15/2011 | US7888285 2,4,6-phenyl substituted cyclic ketoenols |
| 02/15/2011 | CA2617000C Methods for preparing nevirapine hemihydrate and an aqueous suspension thereof |
| 02/15/2011 | CA2558272C Pyridone derivative |
| 02/15/2011 | CA2496842C Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/15/2011 | CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/15/2011 | CA2470067C Imidazoquinoline derivatives |
| 02/15/2011 | CA2461572C Polycyclic compounds having anti-tumor activity |
| 02/15/2011 | CA2377085C Substituted benzimidazoles |
| 02/10/2011 | WO2011017142A1 Novel bicyclic urea compounds |
| 02/10/2011 | WO2011017009A1 Novel azaheterocyclic compounds |
| 02/10/2011 | WO2011016559A1 Heterocyclic compound and use thereof |
| 02/10/2011 | WO2011016528A1 Aminopyrazole derivative |
| 02/10/2011 | WO2011016472A1 Pyridine and pyrimidine derivatives having ttk-inhibiting activity |
| 02/10/2011 | WO2011016202A1 Compound having substituted anthracene ring structure and pyridoindole ring structure and organic electroluminescence device |
| 02/10/2011 | WO2011015936A2 An improved process for the preparation of pure paliperidone |
| 02/10/2011 | WO2011015523A1 Benzyl-substituted tetracyclic heterocyclic compounds |
| 02/10/2011 | WO2011015343A1 Metabotropic glutamate receptor modulators |
| 02/10/2011 | US20110034691 Process for the Production of Fused, Tricyclic Sulfonamides |
| 02/10/2011 | US20110034506 Triazolopyridine compounds useful as dgat1 inhibitors |
| 02/10/2011 | US20110034504 Agent for preventing and/or treating vascular diseases |
| 02/10/2011 | US20110034499 Spiroindolines as modulators of chemokine receptors |
| 02/10/2011 | US20110034497 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
| 02/10/2011 | US20110034495 Method of Modulating Stress-Activated Protein Kinase System |
| 02/10/2011 | US20110034487 Cxcr3 antagonists |
| 02/10/2011 | US20110034475 1-aza-bicyclo[3.3.1]nonanes |
| 02/10/2011 | US20110034469 Heterocyclic Compound |
| 02/10/2011 | US20110034468 Triazolo compounds useful as dgat1 inhibitors |
| 02/10/2011 | US20110034467 Dihydro-pyrrolopyridine-, dihydro-pyrrolopyridazine- and dihydro-pyrrolopyrimidine-derivatives and use thereof |
| 02/10/2011 | US20110034458 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors |
| 02/10/2011 | US20110034457 Pyridothiophene Compounds |
| 02/10/2011 | US20110034455 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| 02/10/2011 | US20110034452 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments |
| 02/10/2011 | US20110034447 Tdp-43-storing cell model |
| 02/10/2011 | US20110034334 Herbicidal compounds |